aspirin has been researched along with fluorobenzenes in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duffy, EM; Jorgensen, WL | 1 |
| Rodda, B; Van Winzum, C | 1 |
| Andrew, A; Rodda, B; Van Winzum, C; Verhaest, L | 1 |
| Hannah, J; Holtz, WJ; Houser, RW; Jones, H; Kelly, KW; Matzuk, AR; Ruyle, WV; Sarett, LH; Shen, TY; Witzel, BE | 1 |
| Majerus, PW; Stanford, N | 1 |
| Anderson, JA; Buchanan, WW; Lee, P; Miller, J; Webb, J | 1 |
| Ahn, YM; Byun, HY; Cho, JY; Cho, SI; Chung, JM; Gwag, BJ; Im, DS; Kim, KW; Ko, SY; Kwon, HJ; Lee, HU; Lee, JY; Lee, MJ; Lee, YA; Lim, HR; Moon, HS; Noh, JH; Park, SM; Son, SJ; Won, SJ; Yoon, SH; Yun, BS | 1 |
| Belizna, C; Favre, J; Gilbert, D; Lartigue, A; Lévesque, H; Richard, V; Thuillez, C; Tron, F | 1 |
| Barillà, F; Donato, L; Petrini, N; Pulcinelli, FM; Riondino, S; Tanzilli, G; Torromeo, C | 1 |
| Gibbons, RJ | 1 |
| Bloom, JM | 1 |
| Amsterdam, EA; Kappagoda, CT | 1 |
| Ballerio, R; Banfi, C; Blanc-Guillemaud, V; Brioschi, M; Castiglioni, L; Gelosa, P; Gianella, A; Guerrini, U; Lerond, L; Nobili, E; Pignieri, A; Sironi, L; Tremoli, E | 1 |
| Ahn, JH; Bliden, KP; Gho, EH; Gurbel, PA; Hwang, JY; Hwang, SJ; Jeong, YH; Kim, S; Kwak, CH; Kwon, TJ; Park, JR; Park, Y; Tantry, US | 1 |
| Borg, JY; Guegan-Massardier, E; Joly, B; Le Cam-Duchez, V; Menard, AL; Ozkul-Wermester, O; Triquenot-Bagan, A | 1 |
4 trial(s) available for aspirin and fluorobenzenes
| Article | Year |
|---|---|
Diflunisal: efficacy in postoperative pain.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Fluorobenzenes; Humans; Male; Middle Aged; Pain, Postoperative; Placebos; Salicylates; Time Factors | 1977 |
Diflunisal: six-month experience in osteoarthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Drug Evaluation; Fluorobenzenes; Humans; Ibuprofen; Osteoarthritis; Patient Dropouts; Salicylates; Time Factors | 1977 |
[Comparative evaluation of the therapeutic efficiency of flurbiprofene in rheumatoid polyarthritis].
Topics: Acetaminophen; Arthritis, Rheumatoid; Aspirin; Biphenyl Compounds; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Fluorobenzenes; Flurbiprofen; Humans; Indomethacin; Mefenamic Acid; Pain; Phenylpropionates; Placebos; Prednisone; Propionates | 1975 |
Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
Topics: Adenosine Diphosphate; Aspirin; Atorvastatin; Calcium Channel Blockers; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP3A; Drug Substitution; Drug Therapy, Combination; Female; Fluorobenzenes; Genotype; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Prospective Studies; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Ticlopidine | 2012 |
11 other study(ies) available for aspirin and fluorobenzenes
| Article | Year |
|---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Discovery of diflunisal.
Topics: Acetylation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chemistry, Pharmaceutical; Fluorobenzenes; History, 20th Century; Salicylates; Structure-Activity Relationship; United States | 1977 |
Comparative effects of aspirin and diflunisal on prostaglandin synthetase from human platelets and sheep seminal vesicles.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Fluorobenzenes; Humans; In Vitro Techniques; Male; Mixed Function Oxygenases; Salicylates; Seminal Vesicles; Sheep | 1977 |
Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine.
Topics: Animals; Antioxidants; Aspirin; Benzoates; Brain Ischemia; Cells, Cultured; Excitatory Amino Acid Antagonists; Fluorobenzenes; Infarction, Middle Cerebral Artery; meta-Aminobenzoates; Mice; N-Methylaspartate; Oxidative Stress; Receptors, N-Methyl-D-Aspartate; Salicylates; Sulfasalazine | 2007 |
Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?
Topics: Acetylcholine; Animals; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Antiphospholipid Syndrome; Aspirin; Endothelium, Vascular; Fluorobenzenes; Free Radicals; Immunohistochemistry; Male; Mice; Nitric Oxide; Prostaglandins; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vasodilation | 2008 |
Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Pyrimidines; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides; Ticlopidine | 2009 |
Rosuvastatin in patients with elevated C-reactive protein.
Topics: Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fluorobenzenes; Guideline Adherence; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Smoking; Sulfonamides | 2009 |
Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Patient Selection; Pyrimidines; Research Design; Rosuvastatin Calcium; Sulfonamides | 2009 |
Another look at the results of the JUPITER trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Female; Fluorobenzenes; Guideline Adherence; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Pyrimidines; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2009 |
Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin.
Topics: Animals; Aspirin; Biomarkers; Blood Pressure; Brain; Endothelium, Vascular; Fluorobenzenes; Hypertension; Magnetic Resonance Imaging; Male; Naphthalenes; Propionates; Protective Agents; Pyrimidines; Rats; Rats, Inbred SHR; Receptors, Prostaglandin; Receptors, Thromboxane; Rosuvastatin Calcium; Stroke; Sulfonamides; Survival Analysis; Systemic Inflammatory Response Syndrome | 2010 |
Involvement of Arg306 mutation in factor V gene in two young men with ischemic stroke.
Topics: Anticholesteremic Agents; Arginine; Aspirin; Brain Ischemia; DNA Mutational Analysis; Factor V; Fibrinolytic Agents; Fluorobenzenes; Humans; Intracranial Thrombosis; Male; Middle Aged; Mutation; Pyrimidines; Rosuvastatin Calcium; Stroke; Sulfonamides; Young Adult | 2014 |